Author | Year | Country | Total number of patients | Mean age | Clinical stage | Treatment | Number of patients with HPV-16 positive | Number of patients with HPV-18 positive | Median DFS | Median PFS | Median OS |
---|---|---|---|---|---|---|---|---|---|---|---|
Mi Chen | 2019 | China | 131 | 29–61 | I-III | adjuvant radiation | 88 | 19 | HR: 1.13, 95% CI = 0.78–1.64 | NA | HR: 1.39, 95% CI = 1.14–1.69 |
Yuanyuan Wang | 2018 | China | 232 | NA | I-III | adjuvant radiation | 108 | 19 | NA | Not significant | HR: 2.17, 95% CI = 1.20–3.92 |
Ruihong Lan | 2017 | China | 40 | 40.21 | II-III | adjuvant radiation | 22 | 10 | NA | NA | HR: 1.15, 95% CI = 1.01–1.31 |